Abstract:Chemotherapy offers a systemic cancer treatment; however, it is limited in clinical administration due to its serious side effects. In cancer medicine, the use of nanoparticles (NPs) drug delivery system (DDS) can sustainedly release anticancer drug at the specific site and reduce the incidence of toxicity in normal tissues. In the present study, we aimed to evaluate the benefit of a novel chemotherapeutic DDS and its underlying mechanisms. Daunorubicin (DNR) was loaded into poly (lactic-co-glycolic acid) (PLGA)-poly-L-lysine (PLL)-polyethylene glycol (PEG)-transferrin (Tf) NPs to construct DNR-PLGA-PLL-PEG-Tf-NPs (DNR-loaded NPs) as a DDS. After incubating with PLGA-PLL-PEG-Tf-NPs, DNR, and DNR-loaded NPs, the leukemia K562 cells were collected and the intracellular concentration of DNR was detected by flow cytometry, respectively. Furthermore, the effect of drugs on the growth of tumors in K562 xenografts was observed and the relevant toxicity of therapeutic drugs on organs was investigated in vivo. Meanwhile, cell apoptosis in the excised xenografts was measured by transferase-mediated dUTP nick-end labeling assay, and the expression of apoptosis-related proteins, including Bcl-2, Bax, Caspase-9, Caspase-3, and cleaved-PARP, was determined by Western blotting analysis. Results showed that DNR-loaded NPs increased intracellular concentration of DNR in K562 cells in vitro and induced a remarkable improvement in anticancer activity in the xenografts in vivo. The expression of Bcl-2 protein was downregulated and that of Bax, Caspase-9, Caspase-3, and cleaved-PARP proteins were obviously upregulated in the DNR-loaded NPs group than that in other ones. Interestingly, pathological assessment showed no apparent damage to the main organs. In summary, the results obtained from this study showed that the novel NPs DDS could improve the efficacy of DNR in the treatment of leukemia and induce apoptosis via intrinsic pathway. Thus, it can be inferred that the new drug delivery may be a useful clinical tool.

Uptake of albumin nanoparticles by NB4 cells and the anti-tumor effect of dihydrotanshinone Ⅰ loaded albumin nanoparticles on the cells

Preparation and antitumor effects of tanshinone ⅡA loaded albumin nanoparticles]

Albumin Nanoparticle Encapsulation of Potent Cytotoxic Therapeutics Shows Sustained Drug Release and Alleviates Cancer Drug Toxicity.

Biguanides Decorated Albumin Nanoparticles Loading Nintedanib for Synergic Enhanced Hepatocellular Carcinoma Therapy

Enhanced Tumor Delivery and Antitumor Response of Doxorubicin-Loaded Albumin Nanoparticles Formulated Based on a Schiff Base.

[Basic Research on Therapy of Leukemia with Nanoparticles Drug Delivery System Modified by Transferrin Receptor Monoclonal Antibody].

Coomassie Bright Blue-Conjugated Human Serum Albumin Nanoparticles As a Tumor-Selective Weapon for Leukemia Therapy

Aptamer-functionalized Albumin-Based Nanoparticles for Targeted Drug Delivery

Efficient Tumor-Targeting Delivery of Sirna Via Folate-Receptor Mediated Biomimetic Albumin Nanoparticles Enhanced by All-Trans Retinoic Acid

The proliferation inhibition of K562 cells by albumin nanoparticles with As;O

Human Albumin Fragments Nanoparticles As PTX Carrier for Improved Anti-cancer Efficacy.

PLGA-PLL-PEG-Tf-based Targeted Nanoparticles Drug Delivery System Enhance Antitumor Efficacy Via Intrinsic Apoptosis Pathway

Bufalin-loaded bovine serum albumin nanoparticles demonstrated improved anti-tumor activity against hepatocellular carcinoma: preparation, characterization, pharmacokinetics and tissue distribution.

In situ low-immunogenic albumin-conjugating-corona guiding nanoparticles for tumor-targeting chemotherapy

Cloaking Mesoporous Silica Nanoparticles with Phenylboronic Acid-Conjugated Human Serum Albumin-Co-polydopamine Films for Targeted Drug Delivery

Specific Cancer Stem Cell-Therapy by Albumin Nanoparticles Functionalized with CD44-mediated Targeting

Intravital Microscopy Reveals Endothelial Transcytosis Contributing to Significant Tumor Accumulation of Albumin Nanoparticles.

Selenium‐doped albumin nanoparticles enhance tamoxifen‐induced anticancer effects in 4T‐1 mouse breast cancer cells

Small Fluorescent Albumin Nanoparticles for Targeted Photothermal Therapy Via Albumin-Binding Protein Pathways

Rgd-Conjugated Albumin Nanoparticles As A Novel Delivery Vehicle in Pancreatic Cancer Therapy

Preparation and tumor-targeting evaluation of BS-CyP albumin nanoparticles modified with hyaluronic acid based on boron neutron capture therapy